These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1913524)

  • 1. Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence.
    Gerbes AL; Jüngst D; Xie YN; Permanetter W; Paumgartner G
    Cancer; 1991 Oct; 68(8):1808-14. PubMed ID: 1913524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
    Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
    Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
    Gerbes AL; Xie YN; Mezger J; Jüngst D
    Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology.
    Gulyás M; Kaposi AD; Elek G; Szollár LG; Hjerpe A
    J Clin Pathol; 2001 Nov; 54(11):831-5. PubMed ID: 11684715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascitic fluid cholesterol in malignant and tubercular ascites.
    Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
    J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.
    Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ
    J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
    Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
    Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinoembryonic antigen (CEA) in ascites].
    Coenen C; Schmidt G; Wegener M; Wedmann B; Bauer KH; Ricken D
    Fortschr Med; 1991 Apr; 109(13):280-2. PubMed ID: 2066045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical markers of the tumor origin of ascites].
    Romette J; di Costanzo-Dufetel J
    Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen assay of ascites and detection of malignancy.
    Loewenstein MS; Rittgers RA; Feinerman AE; Kupchik HZ; Marcel BR; Koff RS; Zamcheck N
    Ann Intern Med; 1978 May; 88(5):635-8. PubMed ID: 646247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy.
    Mortensen PB; Kristensen SD; Bloch A; Jacobsen BA; Rasmussen SN
    Scand J Gastroenterol; 1988 Nov; 23(9):1085-8. PubMed ID: 3247589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
    Gulyás M; Elek G; Molnár M; Szollár L
    Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human chorionic gonadotropin-beta in the differentiation of malignancy-related and nonmalignant ascites.
    Gerbes AL; Hoermann R; Mann K; Jüngst D
    Digestion; 1996; 57(2):113-7. PubMed ID: 8786000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ascitic fluid: benignancy and malignancy parameters].
    Fluixá Carrascosa F; Rull Segura S; Devesa Jorda F; Martín Estruch A; Tur Cotaina MD; Borghol Hariri A; Pérez Serra J
    Rev Esp Enferm Dig; 1996 Jan; 88(1):35-8. PubMed ID: 8615999
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
    Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
    Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of carcinoembryonic antigen in malignancy-related ascites: systematic review and meta-analysis.
    Ahadi M; Tehranian S; Memar B; Vossoughinia H; Salari M; Eskandari E; Farzanehfar M; Sadeghi R
    Acta Gastroenterol Belg; 2014 Dec; 77(4):418-24. PubMed ID: 25682632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined carcinoembryonic antigen and cytopathologic examination in ascites.
    Torresini RJ; Prolla JC; Diehl AR; Morais EK; Jobim LF
    Acta Cytol; 2000; 44(5):778-82. PubMed ID: 11015979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
    Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.
    Prieto M; Gómez-Lechón MJ; Hoyos M; Castell JV; Carrasco D; Berenguer J
    Dig Dis Sci; 1988 Jul; 33(7):833-8. PubMed ID: 2837370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
    Rana SV; Babu SG; Kocchar R
    Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.